• SENSEX 76,291.86
    -325.58 (--0.42%)
  • BANKNIFTY 51,348.05
    520.55 (+1.02%)
  • Mazagon Dock
    2,720.00 2,929.98(%)
  • Tejas Networks
    902.70 1,495.10(%)
  • Kalyan Jewellers
    497.15 337.00(%)
  • Adani Power
    538.00 896.75(%)
  • Reliance Industr
    1,234.55 1,156.00(%)
  • Hind.Aeronautics
    4,309.00 5,675.00(%)
  • TCS
    3,396.10 3,457.35(%)
  • Bharat Electron
    288.30 340.35(%)
  • Persistent Sys
    4,783.75 3,232.60(%)
  • Vodafone Idea
    8.06 6.60(%)
  • Tata Motors
    655.20 606.20(%)
  • Infosys
    1,485.10 1,359.10(%)
  • Jio Financial
    231.75 394.70(%)
  • Emcure Pharma
    1,040.30 911.75(%)
  • Reliance Power
    44.44 54.25(%)
  • IndusInd Bank
    714.65 1,576.00(%)
  • ICICI Bank
    1,306.55 1,048.35(%)
  • Zomato Ltd
    214.00 304.50(%)
  • Zydus Lifesci.
    949.85 1,323.90(%)
  • ICICI Pru. BSE
    1,000.01 1,197.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

ANG Lifesciences India Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70392.0
  • ISIN : INE236W01016
25.04 1 (4.99%)
  • As on 03 Apr 2025 (EOD)

  • Today’s Low

    25.04

  • Today’s High

    25.04

  • Open

    25.04

  • Perv Close

    23.85

  • 52W Low

    21.03

  • 52W High

    63.17

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    32.70

  • Div & Yield %

    0.00

  • Book Value(₹)

    56.15

  • Debt-Equity Ratio

    4.99

  • AGM Date

    02-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.88

  • Mar.Cap (₹Cr.)

    32.70

  • RONW (%)

    -10.56

  • ROCE (%)

    1.43

Score Board

  • Equity (₹ in Cr.)

    13.06

  • BV (₹)

    56.20

  • Sales( ₹ in Cr.)

    131.37

  • NP (in Cr.)

    -7.08

  • NP Var(%)

    -1707.0

  • Div%

    0.0

  • CPS (₹)

    0.50

  • EPS (₹)

    -5.40

  • Traded Value (₹ in Lakhs)

    32.70

  • 52 Week High

    63.17

  • 52 Week Low

    21.03

  • Price BSE

    25.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    32.70

  • P/C Ratio

    48.60

  • P/E Ratio

    -4.60

  • Price Vs.BV

    -5.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019
Sales Turnover 131.37 207.01 348.67 154.28 126.83 121.70
Excise Duty 131.33 206.67 346.83 149.24 125.36 121.66
Net Sales 131.37 207.01 348.67 154.28 126.83 121.70
Other Income 0.84 9.84 0.95 0.75 0.42 0.23
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 132.20 216.85 349.62 155.02 127.25 121.93
EXPENDITURE :
Raw Materials 131.33 206.67 346.83 149.24 125.36 121.66
Power & Fuel Cost 131.33 206.67 346.83 149.24 125.36 121.66
Employee Cost 15.90 20.27 18.32 14.35 7.94 6.90
Other Manufacturing Expenses 1.59 2.71 3.11 1.00 3.40 3.88
Selling & Administrative Expenses 13.04 18.21 23.49 13.56 10.42 8.75
Miscellaneous Expenses 1.59 2.71 3.11 1.00 3.40 3.88
Less : Pre-operative Expenses Capitalised :
Total Expenditure 139.34 214.78 296.56 145.16 118.84 113.82
Operating Profit 4.52 7.84 8.65 6.48 4.03 2.99
Interest 9.33 10.32 7.85 3.58 2.87 2.34
Gross Profit -8.87 2.07 53.06 9.86 8.41 8.11
Depreciation 7.75 8.52 5.12 2.24 1.23 1.12
Profit Before Tax -8.87 2.07 53.06 9.86 8.41 8.11
Tax 0.00 2.11 13.47 3.18 2.40 2.37
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.22 0.62 -0.11 -0.57 -0.09 0.03
Reported Net Profit -8.65 -0.66 39.71 7.25 6.10 5.65
Extraordinary Items -8.87 2.07 53.06 9.86 8.41 8.11
Adjusted Net Profit -8.65 -0.66 39.71 7.25 6.10 5.65
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 0.00 0.00 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 1.04 0.00 0.00 0.00
P & L Balance carried down -8.65 -0.66 39.71 7.25 6.10 5.65
Dividend - - - - - -
Preference Dividend - - - - - -
Equity Dividend (%) 0.00 0.00 10.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 1.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -6.48 0.04 38.51 12.63 11.76 10.90
Book Value 0.00 0.00 1.04 0.00 0.00 0.00
Book Value(Adj)-Unit Curr 0.00 0.00 1.04 0.00 0.00 0.00

Shareholding Pattern

  • Promoter Group

    70.60%

  • Public Share Holding

    29.40%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 9,219,537 70.60 9,219,537 2
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 9,219,537 70.60 9,219,537 2
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 29,328 0.22 29,328 19
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 240,193 1.84 240,193 80
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 788,747 6.04 788,747 23
Individuals holding nominal share capital up to Rs. 1 lakh 2,595,900 19.88 2,591,350 6,286
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 184,582 1.41 184,582 107
Sub Total 3,838,750 29.40 3,834,200 6,515
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 13,058,287 100.00 13,053,737 6,517

Company Background

ANG Lifesciences India LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • ANG Lifesciences India Ltd
  • BSE Code : 70392.0
  • ISIN : INE236W01016

  • Incorporation Year

    2006

  • Registered Office

    Darbara Complex SCO 113 I Flr
    Dist. Shopping Centre B Block, Amritsar,
    Punjab-143001

  • Telephone

    91-0183-5070118/5070119

  • FAX

  • Chairman

  • Managing Director

    Rajesh Gupta

  • Company Secretary

    Renu

  • Auditor

    Khurana Sharma & Co/Raman Wadhwa & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Bigshare Services Pvt Ltd
    E-2/3 Ansa Indl Est,
    Saki Vihar Road ,Sakinaka Andheri(E)
    Mumbai - Mumbai - 400072

ANG Lifesciences India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
ANG Lifesciences 25.04 132.20 131.37 -2.72 1.71
Abbott India 29,572.60 6,097.18 5,848.91 47.09 44.71
Astrazeneca Phar 8,100.10 1,330.33 1,295.53 208.82 33.26
P & G Health Ltd 5,259.35 1,166.89 1,151.26 36.90 39.76
Glaxosmi. Pharma 2,776.60 3,530.73 3,407.25 55.21 44.44
Cipla 1,452.70 17,645.00 16,574.34 24.90 20.10
Amrutanjan Healt 645.10 437.58 421.23 37.81 20.84
Fermenta Biotec. 292.05 315.24 307.09 27.68 4.10
Guj. Themis Bio. 272.20 174.19 169.82 56.36 44.82
Bliss GVS Pharma 120.00 638.96 605.46 27.46 11.19
Ambalal Sarabhai 37.31 11.70 3.81 15.94 1.92